Sell this medical testing stock poised to fall more than 15% from here, Citi says in downgrade

By November 18, 2022Health

It’s time for investors to sell this medical testing stock, Citi says.

Spread the love
See also  China touts vaccination progress as it seeks reopening path; encourages booster shots for seniors

Leave a Reply